Jasmaine McClain

Jasmaine McClain advises clients on quality landscape developments and quality improvement implementation.

She draws on her expertise in oncology research, innovations in virtual care, and provider strategy.

Prior to joining Avalere, Jasmaine was an Associate Director at Advisory Board where she advised senior leaders in hospitals and health systems in devising long-term operational strategies related to digital health and healthcare delivery transformation. In a previous position, she led the creation of best-practice research presentations, infographics, and white papers on telehealth strategy and implementation for hospitals and health systems. Additionally, she has conducted research on the impact of Vitamin D deficiency on breast cancer metastasis.

Jasmaine has a PhD in cancer biology and an MS in medicine from Stanford University. She has a BS in biology and a BA in Spanish from University of Georgia.

Authored Content

The COVID-19 pandemic has disproportionately impacted seniors nationwide, with this population at an increased risk of hospitalization or death following a COVID-19 diagnosis.

Join Avalere’s panel of policy, public health, and regulatory experts to learn about the challenges, opportunities, and key milestones to watch.

On December 14, 2020, an intensive care unit nurse in New York was the first American to receive an injection of the COVID-19 vaccine.

In response to the COVID-19 public health emergency and recent social events highlighting systemic inequities, life sciences companies have issued bold statements reaffirming their commitment to diversity, inclusion, and health equity.

The COVID-19 pandemic has disproportionately impacted communities of color since the first cases were identified in the United States.

Rising healthcare costs and the increased prevalence of chronic disease in the US are incentivizing stakeholders to develop new solutions to tackle these issues. Many have turned to digital health innovations like mobile health applications to facilitate care prevention and management for chronic disease, but significant gaps remain in their ability to be used in real-world practice.

Digital health remains a powerful focal point in the push towards value-based healthcare. Across multiple domains, emerging technologies provide promising strategies for delivering more effective, efficient, and personalized care.

Remote patient monitoring (RPM) provides an opportunity to diagnose and treat patients facing neurological diseases. Given that multiple sclerosis (MS), Parkinson’s disease, and epilepsy require intervention from specialized care teams, effective management of these chronic neurological conditions can be supported through RPM to improve patient outcomes. Although RPM has been shown to be a complement and in some cases an alternative to office-based care, reimbursement and coverage barriers remain.

With increasing legislative and regulatory activity promoting adoption of digital health, interest has continued to expand in 2019.

The National Academies issued a report identifying several key factors and recommendations for integrating social care into healthcare delivery.